This article was originally published in The Rose Sheet
"Increased awareness of consumer exposure may lead to increased demand for regulation/risk assessment" for cosmetic products, the European Commission states in a recently-released 1report evaluating the activities and future needs of scientific committees under the Health and Consumer Protection Directorate General, including the Scientific Committee on Cosmetics and Non-Food Products. Report cites hair dyes as an example in which a study linking the products to bladder cancer triggered review of 100 ingredients that had been marketed in the EU without restrictions. Commission estimates SCCNFP evaluates 20-40 hair dye ingredients a year, as well as six to 10 preservatives and a similar number of UV filters...
You may also be interested in...
There is speculation that it is the end of the road for abicipar pegol but Allergan has declined to say whether this is the case for the product that has been in development for wet AMD.
In the EU, voices calling for a postponement of the IVD Regulation’s 2022 enforcement date are growing louder.
After talking with the FDA, Atox will file an NDA for its necrotizing soft tissue infections therapy despite missing primary endpoints in a pivotal trial, the biotech’s CEO tells Scrip.